Stocks › PGEN
PRECIGEN, INC.
PGEN·Nasdaq·
United States·USD
United States·USD$6.94
+0.30 (+4.52%)
Close · Oct 30, 2026 · Close Prices from Tiingo.com
PGEN
PRECIGEN, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PGENS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of PGEN by members of U.S. Congress · 0 on record
No congressional trades in PGEN on record.
Whale Activity
Position changes in PGEN reported for 2026-09-30 by 4 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing4
| Filer | Shares | Value | Change |
|---|---|---|---|
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3.1M | $26.2M | — |
| LexAurum Advisors, LLC | 633.5K | $5.4M | — |
| Overbrook Management Corp | 30.0K | $257K | — |
| Alpha Advisors, LLC/VA | 20.2K | $173K | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by PGEN insiders, by quarter · Form 4
Recent Insider Transactions
565 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Thomasian Harry Jr.Chief Financial Officer | Option exercise | +1 | $1.21 | $1 | Sep 23, 2026 | Form 4 ↗ |
| Thomasian Harry Jr.Chief Financial Officer | Option exercise | +2 | $0.96 | $2 | Sep 23, 2026 | Form 4 ↗ |
| Thomasian Harry Jr.Chief Financial Officer | Option exercise | +42.9K | $2.33 | $100K | Sep 23, 2026 | Form 4 ↗ |
| Thomasian Harry Jr.Chief Financial Officer | Option exercise | +10.7K | $4.72 | $51K | Sep 23, 2026 | Form 4 ↗ |
| KINDLER JEFFREY BDirector | Sale | −185.0K | $7.44 | $1.4M | Aug 26, 2026 | Form 4 ↗ |
| Shah Rutul RChief Operating Officer | Sale | −15.3K | $7.50 | $115K | Aug 25, 2026 | Form 4 ↗ |
| Shah Rutul RChief Operating Officer | Option exercise | +15.3K | $2.33 | $36K | Aug 25, 2026 | Form 4 ↗ |
| Tennant PhilChief Commercial Officer | Sale | −79.2K | $7.50 | $594K | Aug 25, 2026 | Form 4 ↗ |
| Tennant PhilChief Commercial Officer | Option exercise | +79.2K | $1.61 | $127K | Aug 25, 2026 | Form 4 ↗ |
| Lehr Donald P.Chief Legal Officer | Tax withholding | −2,488 | $7.20 | $18K | Aug 23, 2026 | Form 4 ↗ |
| Lehr Donald P.Chief Legal Officer | Option exercise | +5,208 | — | — | Aug 23, 2026 | Form 4 ↗ |
| Thomasian Harry Jr.Chief Financial Officer | Tax withholding | −3,577 | $7.20 | $26K | Aug 23, 2026 | Form 4 ↗ |
| Thomasian Harry Jr.Chief Financial Officer | Option exercise | +7,291 | — | — | Aug 23, 2026 | Form 4 ↗ |
| Shah Rutul RChief Operating Officer | Tax withholding | −3,647 | $7.20 | $26K | Aug 23, 2026 | Form 4 ↗ |
| Shah Rutul RChief Operating Officer | Option exercise | +7,500 | — | — | Aug 23, 2026 | Form 4 ↗ |
| Tennant PhilChief Commercial Officer | Tax withholding | −2,585 | $7.20 | $19K | Aug 23, 2026 | Form 4 ↗ |
| Tennant PhilChief Commercial Officer | Option exercise | +5,208 | — | — | Aug 23, 2026 | Form 4 ↗ |
| Sabzevari HelenPresident and CEO | Tax withholding | −10.2K | $7.20 | $73K | Aug 23, 2026 | Form 4 ↗ |
| Sabzevari HelenPresident and CEO | Option exercise | +20.8K | — | — | Aug 23, 2026 | Form 4 ↗ |
| AGEE NANCY HDirector | Purchase | +3,411 | $7.23 | $25K | Aug 21, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding PGEN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Patient Opportunity Trust Advisor Managed Portfolios | 12.9M | $73.5M | 3.66% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 7.1M | $40.4M | 0.38% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.7M | $32.4M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 5.0M | $28.2M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 2.1M | $13.2M | 0.04% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.0M | $11.5M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1.7M | $10.5M | 0.12% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 1.8M | $10.2M | 0.07% | Jun 30, 2026 |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 1.5M | $9.7M | 0.74% | Jul 31, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 1.1M | $7.7M | 0.04% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list PGEN's shares (CUSIP 74017N105), each fund at its latest report since Apr 2, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- E. Merck KG, Darmstadt GermanySCHEDULE 13G/A · passive (13G) · 17.5M shares4.9%
Aug 7, 2026 · ↗ - Merck KGaA, Darmstadt, GermanySCHEDULE 13G/A · passive (13G) · 17.5M shares4.9%
Aug 7, 2026 · ↗ - Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, DarmstadtSCHEDULE 13G/A · passive (13G) · 17.5M shares4.9%
Aug 7, 2026 · ↗ - Ares Trading SASCHEDULE 13G/A · passive (13G) · 17.5M shares4.9%
Aug 7, 2026 · ↗ - Steven A. CohenSCHEDULE 13G/A · passive (13G) · 6.7M shares1.9%
May 15, 2026 · ↗ - Point72 Capital Advisors, Inc.SCHEDULE 13G/A · passive (13G) · 6.7M shares1.9%
May 15, 2026 · ↗ - Point72 Asset Management, L.P.SCHEDULE 13G/A · passive (13G) · 6.7M shares1.9%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming precigen as client
No lobbying filings found naming PRECIGEN, INC. as the client.
- BAILEY STRATEGIC ADVISORS, LLCPRECIGEN INC FORMERLY REPORTED AS INTREXON CORPORATION · 2020 Q2$20K
Filing ↗ - BAILEY STRATEGIC ADVISORS, LLCPRECIGEN INC FORMERLY REPORTED AS INTREXON CORPORATION · 2020 Q2$20K
Filing ↗ - BAILEY STRATEGIC ADVISORS, LLCPRECIGEN INC FORMERLY REPORTED AS INTREXON CORPORATION · 2020 Q1$20K
Filing ↗ - BAILEY STRATEGIC ADVISORS, LLCPRECIGEN INC FORMERLY REPORTED AS INTREXON CORPORATION · 2019 Q4 · TRD, AGR$20K
Filing ↗ - BAILEY STRATEGIC ADVISORS, LLCPRECIGEN INC FORMERLY REPORTED AS INTREXON CORPORATION · 2019 Q3 · TRD, AGR$20K
Filing ↗
Government Contracts
Federal awards to PRECIGEN, INC. · USAspending
No federal contract awards found for PRECIGEN, INC..
U.S. Patents
Recent USPTO applications naming PRECIGEN, INC.
No USPTO patent applications found for PRECIGEN, INC..
Annual Financials
From PGEN's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.7M | $3.9M | $6.2M | $26.9M | $14.3M |
| Operating income | -$110.5M | -$135.0M | -$99.8M | n/a | n/a |
| Net income | -$250.6M | -$126.2M | -$95.9M | $28.3M | -$92.2M |
| Diluted EPS | -$1.37 | -$0.47 | -$0.39 | $0.14 | -$0.47 |
| Operating cash flow | -$87.8M | -$68.2M | -$66.9M | -$65.0M | -$55.8M |
| Cash and equivalents | $30.2M | $29.5M | $7.6M | $4.9M | $36.4M |
| Total assets | $155.5M | $145.3M | $151.0M | $216.0M | $359.9M |
| Total liabilities | $134.6M | $78.5M | $32.5M | $89.7M | $252.5M |
| Shareholders' equity | $20.9M | $38.5M | $118.5M | $126.3M | $107.3M |
As PRECIGEN, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 25, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 92-for-91Stock splitJan 19, 2017
- 27-for-26Stock splitJun 9, 2015
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02Results of operationsAug 4, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 24, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 13, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.02, 3.03, 5.03, 7.01, 8.01, 9.01Material agreement · Unregistered sale of equity · Modification of rightsDec 30, 2024
EDGAR ↗
About PRECIGEN, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersGERMANTOWN, MD
IncorporatedVA
SEC CIK0001356090 ↗
Former namesINTREXON CORP